Abstract This study aimed to elucidate the genetic relatedness and epidemiology of 127 clinical and environmental Candida glabrata isolates from Europe and Africa using multilocus microsatellite analysis. Each isolate was first identified using phenotypic and molecular methods and subsequently, six unlinked microsatellite loci were analyzed using automated fluorescent genotyping. Genetic relationships were estimated using the minimum-spanning tree (MStree) method. Microsatellite analyses revealed the existence of 47 different genotypes. The fungal population showed an irregular distribution owing to the over-representation of genetically different infectious haplotypes. The most common genotype was MG-9, which was frequently found in both European and African isolates. In conclusion, the data reported here emphasize the role of specific C. glabrata genotypes in human infections for at least some decades and highlight the widespread distribution of some isolates, which seem to be more able to cause disease than others.
Introduction
Candida glabrata is a haploid yeast historically believed to be harmless to humans and for a long time regarded as a nonpathogenic saprophyte of the normal flora of healthy individuals [1] . However, in recent decades, this view has been gradually weakened as a growing number of clinical reports have shown that this fungus is, on the contrary, an important pathogen [2] [3] [4] .
The increase in patients with an impaired immune system, in addition to the widespread use of immunosuppressive therapies and broad-spectrum antibiotic drugs, has greatly contributed to rendering C. glabrata one of the most commonly isolated yeasts among all non-C. albicans species that infect humans [2] [3] [4] . However, although Candida albicans remains the most frequently isolated fungal pathogen in humans, C. glabrata has been reported to be an significant cause of oral infections, especially in elderly people [4, 5] . In addition, this species also shows a remarkable ability to infect other human body sites including the vagina and urinary tract [6, 7] , and in recent years it has undoubtedly emerged as the second-leading cause of bloodstream infections (BSIs) in the USA and in Northern and Central European countries [3] .
The reasons for the increased isolation rate of C. glabrata are multifactorial and difficult to pinpoint exactly. However, the issue of resistance to azole derivatives [3, 8] and the discovery and evolution of new strains [9, 10] are certainly partly responsible.
For population genetics studies in C. glabrata, microsatellites have increasingly become the markers of choice [11] [12] [13] [14] . Most microsatellites are noncoding DNA, either in intergenic sequence regions or in introns. Thus, they can generally be assumed to evolve neutrally; thus, their level of polymorphism is proportional to the underlying mutation rate.
In this study, we report the genetic profiles, obtained through analysis of six microsatellite loci, of different clinical and environmental C. glabrata isolates from Europe and Africa. Our data showed a south-north and east-west distribution of closely related genotypes and highlight the widespread distribution of particular haplotypes, which seem to be more able to cause infections than others.
Materials and methods
A total of 127 C. glabrata isolates, of different clinical and geographical origin, were examined in this study (Table 1 ). All isolates were initially identified by the ID 32C system (bioMeriéux, France) and subsequently confirmed using a species-specific multiplex PCR-based method that allows C. glabrata to be discriminated from its closely related species Candida bracarensis and Candida nivariensis [15, 16] .
Multilocus analysis of polymorphic microsatellite markers was used to evaluate genetic relatedness among our C. glabrata isolates [11] . Six microsatellite markers were amplified by PCR using six pairs of primers, as described in Abbes et al. [11] . For automatic allele size determination the forward primer of each pair was 5′-fluorescently labelled with 6-carboxyfluorescein (FAM; GLM4-Fwd, GLM6-Fwd, RPM2-Fwd and MTI-Fwd primers), 6-carboxyhexafluorescein (HEX; GLM5-Fwd primer), and 6-carboxytetramethylrhodamine (TAMRA; ERG3-Fwd primer). For each isolate, six separate PCR amplifications were performed and amplicons were sent out to Eurofins-MWG/Operon (www.eurofinsdna.com) for fragment length analysis using an ABI 3130XL sequencing platform (Applied Biosystems) and GeneScan 500-ROX as the size standard. Allele binning was carried out using the program AutoBin [17] . Genetic relationships were estimated using the minimum-spanning tree (MStree) method, as implemented in BioNumerics, version 4.61 (Applied Maths, St.-MartensLatem, Belgium).
The discriminatory power (D) of the microsatellite typing method used was calculated on-line (http://insilico.ehu.es/ mini_tools/discriminatory_power/index.php) using Simpson's index of diversity [18] .
For statistical analysis, all isolates were split according to their geographical origin: Africa (n = 22), Greece (n = 15), Italy (n = 30), Portugal (n = 15), Spain (n = 16), Turkey (n = 16) and Middle/Northern Europe (UK, the Netherlands, Austria, Finland, and Germany; n = 13). Haplotype frequencies and genetic diversity within each population in addition to inter-population analysis were computed using the software HAPLOTYPE ANALYSIS version 1.05 (www.unigoettingen.de/en/134935.html). HAPLOTYPE ANALYSIS calculates genetic diversity within each population based on the number of different haplotypes (A) in that population, the number of unique or Bprivate^haplotypes (P) specific to that population, the effective number of haplotypes (Ne) observed in the population, the estimated maximum haplotype richness or Ballele richness^(Rh) defined as the number of alleles per locus and based on the rarefaction method, Nei's index of genetic diversity (He; the probability that two randomly chosen haplotypes are different) estimated without bias and the mean genetic distance between individuals (D sh 2 ) as measures for genetic diversity.
Fisher's exact tests were used to test whether there were statistical differences in the proportion of the genotypes among the different countries. To better quantify the difference between the countries, we used the four clonal complexes (CCs) recognized in the 47 different microsatellite genotypes by the MStree in Fig. 1 . These CCs were grouped into four classes based around the central genotypes.The classified C. glabrata populations were compared using Fisher's exact test giving us the probability that populations were similar (p values >0.05) or dissimilar (p values <0.05).
Results
All yeast isolates examined in this study were identified as C. glabrata isolates and no C. nivariensis or C. bracarensis were recovered. The multilocus microsatellite genotypes obtained are shown in Table 1 and Fig. 1. A total of 84 different alleles were found for the six microsatellite loci analyzed (Table 2) . Locus ERG3 showed the highest genotypic diversity with a D value of 0.85, whereas the lowest genotypic diversity was observed with the locus GLM5 (D = 0.62; Table 2 ).
When all six microsatellite markers were combined, a total of 47 diverse multilocus genotypes (MG) were obtained from 127 C. glabrata isolates (Fig. 1 , Table 1 ). This led to an index of discrimination of 0.89 (Table 2) .
One genotype (MG-9) was the most frequently observed (37 out of 127 isolates; 29 %) followed by genotypes MG-34 (13 out of 127; 10 %), MG-4 (11 out of 127; ∼9 %) and MG-7 (7 out of 127; 5 %). The remaining 43 genotypes were found with an incidence of below 5 % (Table 1 ). In total, we analyzed 51 vaginal samples, 30 blood samples, and 17 from urine as the three most common sample types, whereas the remaining 29 were from a variety of other specimens. However, statistical analysis showed no significant association between the microsatellite genotypes and the origin or date of isolation of our isolates.
The predominant genotype MG-9 was found in 35 clinical samples from different countries and in two environmental samples (insect larvae and malt) in South Africa. Most of the MG-9 isolates were found in Italian (12 out of 37; 32 %) and African (10 out of 37; 27 %) specimens, whereas the remaining isolates were spread over Spain, Greece, and the Middle/ Northern European countries (Fig. 1) . Interestingly, another closely related genotype (MG-4), was also frequently encountered in Italy (3 out of 11; 27 %) and Africa (4 out of 11; 36 %; Turkey  2013  Blood  205  131  238  263  256  321  MG-34  TUR3  Turkey  2014  Urine  228  137  237  275  258  295  MG-18  TUR4  Turkey  2014  Urine  228  125  231  265  270  295  MG-43  TUR5  Turkey  2013  Urine  228  125  237  265  256  321  MG-38  TUR6  Turkey  2014  Urine  262  130  231  275  258  295  MG-19   TUR7  Turkey  2013  Urine  205  131  238  263  256  321  MG-34  TUR8  Turkey  2014  Urine  198  124  236  265  268  287  MG-47  TUR9  Turkey  2014  Urine  205  131  238  263  256  321  MG-34  TUR10  Turkey  2014  CSF  228  125  237  265  256  321  MG-38  TUR11  Turkey  2013  Blood  228  125  237  265  255  321  MG-39   TUR12  Turkey  2015  Urine  198  125  236  272  295  292  MG-46  TUR13  Turkey  2014  Blood  198  125  236  272  295  292  MG-46  TUR14  Turkey  2015  Urine  234  125  237  278  258  321  MG-41   TUR16  Turkey  2014  Urine  243  125  237  268  256  321  MG-40  TUR20  Turkey  2014  Blood  228  125  237  265  256  321  MG-38 BPS biopsy of the paravertebral space, BAL bronchoalveolar lavage, CVC central venous catheter, GM case of generalized mycosis, GI gastrointestinal, RF respiratory fluid, CSF cerebrospinal fluid a Same patient Fig. 1 , Table 1 ). Conversely, the second most common genotype (MG-34) found in this study was exclusively recovered from Portuguese and Turkish clinical samples. This clone, together with the MG-38 genotype and a number of closely related genetic variants, form a particular cluster of isolates evolutionarily distinct from other European isolates (Fig. 1 ). All our observed microsatellite genotypes form a large network in the MStree analysis with no outliers (Fig. 1) . However, several related CCs or microsatellite classes can be defined based on the central, dominant genotypes. For our analysis, we defined four clonal clusters (CC1, CC2, CC3, and CC4) with the following central types MG-34, MG-13, MG-9, and MG-7 respectively (Fig. 1) (Fig. 1) .
According to their geographical origin, our isolates can be subdivided into seven different populations (Table 3) . Even though the populations differed in their sample sizes, the number of haplotypes detected in each population and the numbers of private haplotypes specific to a given population did not differ very much. Portugal and Spain were the two countries with the lowest haplotypic richness and diversity, whereas the highest were in Middle/Northern Europe and Turkey (Table 3) . However, a normalized pairwise population matrix of Nei's genetic distance showed that Portugal and Turkey in particular were more distant from the other countries.
The populations of Africa, Middle/Northern Europe, Italy, Greece, and Spain did not differ significantly from one another (p values >0.05) whereas the Portuguese and Turkish 
Discussions and conclusions
In recent years, important changes in the epidemiology of candidiasis have been observed worldwide, highlighting a significant increase in non-C. albicans species with different degrees of virulence and pathogenicity [3, 15] . Among these species, C. glabrata has emerged as an important cause of human disease, proving to possess an extraordinary ability to infect different body sites [3] [4] [5] [6] [7] 19] . However, based on our results, it seems that not all C. glabrata isolates are equally as likely to cause human infections and some of them, especially those with the MG-9 haplotype, appear to be clinically most relevant and cause disease significantly more often than others (Fig. 1) . This remarkable capacity of some isolates to infect different host tissues may be the result of their unique genetic background (Table 1) . This observation agrees with previous studies [12, 14] and suggests that the identification of specific genotypes could represent an important step for future studies on the virulence of C. glabrata. In this study, the combined analysis of the six microsatellite markers reached a D value of 0.89 and the 127 C. glabrata isolates were divided into 47 different genotypes. Our D value was not consistent with that reported by Abbes et al. [11] , and it is below the desirable value of 0.95 for an Bideal^typing system [20] . Therefore, our results suggest that the present markers should be used with caution if utilized in an attempt to recognize outbreaks of infections, but they can be used for some population studies.
In this study, we were able to recognize at least four CCs. Looking at the distribution of these clonal complexes over the different geographical regions sampled, we observed an expansion of closely related genotypes (MG-9, MG-7, and MG-4) that were prevalent in southern countries (Italy and Spain) and in Africa and were probably spread by the huge flow of migrants that occurs between these two continents. Conversely, two closely related genotypes, MG-34 and MG-38, were restricted only to Turkey and Portugal, even if they showed distantly genetic relationships with the African types MG-37, MG-32, and MG-14. This latter, together with the other Nigerian MG-13, correlates more directly with the main type, MG-9.
The MG-9 type was the most frequently observed genotype spreading between Africa and European countries for long periods of time. In fact, infections caused by this genotype date back to more than 80 years ago (1935) as demonstrated by some C. glabrata strains in the CBS culture collection that were isolated during the two decades between 1935 and 1955 ( Table 1) .
All other clinical isolates were recovered during or after 2004 and the MG-9 genotype was still present in recent clinical samples by demonstrating its exceptional, strong adaptation to specific geographical areas. Hence, the MG-9 seems to be the main European type, while its branching out to other main genotypes via the German MG-8 and the UK sample MG-10 suggests that these branches might have been crucial to the expansion of C. glabrata in Europe.
Even though in part, the same set of microsatellite loci was used in other C. glabrata population studies, it proves difficult to directly compare the results, as small size differences can be observed in the dominant types. These could be due to actual size differences or to errors in the measurements. To avoid such problems in the future we advocate the use of a standard set of reference strains, available from public sources. For this purpose we deposited a representative panel of strains (MGs 7, 9, 13, and 34 in this study) to the CBS culture collection (www.cbs.knaw.nl) in Utrecht, the Netherlands, and the strains are also available from the corresponding author.
In conclusion, the data reported here emphasize the role of specific C. glabrata genotypes in human infections for at least Mean ± SD 18 ± 5.9 9 ± 1.6 5.7 ± 1.7 5.0 ± 1.9 6.3 ± 1.3 0.81 ± 0.12 694 ± 182
N sample size in each population, A number of haplotypes detected in each population, P number of private haplotypes, Ne effective number of haplotypes, Rh haplotypic richness, He genetic diversity, D sh 2 mean genetic distance between individuals, SD standard deviation a few decades. We recommend further genetic studies that may detect a different reality than that currently known with regard to the population structure, epidemiology, and spread of this fungal pathogen.
Compliance with ethical standards
Funding This research was supported in part by the EU Mare Nostrum (EUMN-III Call) program of the European Union, grant agreement number 2011-4050/001-EMA2. Dr Sanae Rharmitt was the recipient of a scholarship (10 months) signed within the EUMN program for PhD students (F.S. 1.04.11.01 UORI) under the supervision of Prof Orazio Romeo.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval This article does not contain any studies with human participants or animals performed by any of the authors.
Informed consent For this type of study formal consent is not required.
